By continuing to use the site you agree to our Privacy & Cookies policy

Your browser seems to have cookies disabled. For the best experience of this website, please enable cookies in your browser.


Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.


New drug for diabetes approved

NICE has approved a drug for treating patients with type 2 diabetes who are intolerant of either metformin, sulphonylurea, thiazolidinediones or dipeptidyl peptidase-4 inhibitors.

Primary care trusts have been ordered by NICE to start funding liraglutide (Victoza), giving 1.2mg daily as a combination treatment. However, it has not approved a 1.8mg dose as the available evidence does not suggest any significant additional benefit.

Have your say

You must sign in to make a comment.

Related Jobs

Sign in to see the latest jobs relevant to you!